Prospera Monetary Providers Inc Purchases New Holdings in UiPath Inc. (NASDAQ:PATH)


Prospera Monetary Providers Inc bought a brand new stake in UiPath Inc. (NASDAQ:PATHGet Score) within the first quarter, in accordance with the corporate in its most up-to-date Kind 13F submitting with the Securities & Trade Fee. The agency bought 1,241 shares of the healthcare firm’s inventory, valued at roughly $27,000.

Quite a lot of different hedge funds and different institutional buyers have additionally modified their holdings of PATH. CarsonAllaria Wealth Administration Ltd. acquired a brand new stake in UiPath through the 4th quarter value $30,000. Benjamin Edwards Inc. grew its holdings in UiPath by 65.4% through the 4th quarter. Benjamin Edwards Inc. now owns 708 shares of the healthcare firm’s inventory value $31,000 after buying a further 280 shares through the interval. Orion Capital Administration LLC acquired a brand new stake in UiPath through the 4th quarter value $43,000. AdvisorNet Monetary Inc grew its holdings in UiPath by 110.0% through the 1st quarter. AdvisorNet Monetary Inc now owns 2,100 shares of the healthcare firm’s inventory value $45,000 after buying a further 1,100 shares through the interval. Lastly, Stephens Inc. AR acquired a brand new stake in UiPath through the 1st quarter value $83,000. Institutional buyers and hedge funds personal 52.19% of the corporate’s inventory.

Insider Exercise at UiPath

In different information, Director Kimberly Hammonds bought 2,521 shares of the inventory in a transaction on Tuesday, June twenty first. The shares have been bought at a mean worth of $18.70, for a complete transaction of $47,142.70. Following the completion of the sale, the director now straight owns 100,662 shares within the firm, valued at $1,882,379.40. The transaction was disclosed in a submitting with the SEC, which is obtainable at this hyperlink. 31.88% of the inventory is owned by insiders.

UiPath Buying and selling Up 3.5 %

Shares of PATH inventory opened at $20.70 on Friday. UiPath Inc. has a 1 12 months low of $13.66 and a 1 12 months excessive of $65.60. The agency’s fifty day shifting common worth is $19.64 and its two-hundred day shifting common worth is $23.42. The agency has a market capitalization of $11.28 billion, a P/E ratio of -26.88 and a beta of 0.09.

UiPath (NASDAQ:PATHGet Score) final launched its quarterly earnings knowledge on Wednesday, June 1st. The healthcare firm reported ($0.23) earnings per share for the quarter, lacking the consensus estimate of ($0.16) by ($0.07). UiPath had a unfavourable return on fairness of 18.47% and a unfavourable internet margin of 42.95%. The agency had income of $245.07 million for the quarter, in comparison with analyst estimates of $225.37 million. Throughout the identical quarter within the prior 12 months, the agency earned ($0.81) earnings per share. The agency’s income for the quarter was up 31.6% on a year-over-year foundation. As a bunch, equities analysis analysts forecast that UiPath Inc. will publish -0.59 EPS for the present fiscal 12 months.

Analyst Scores Modifications

Quite a lot of analysts have commented on PATH shares. Canaccord Genuity Group reaffirmed a “purchase” ranking and set a $25.00 goal worth on shares of UiPath in a report on Thursday, July seventh. BMO Capital Markets diminished their worth goal on shares of UiPath from $29.00 to $21.00 in a analysis report on Thursday, June 2nd. Wells Fargo & Firm diminished their worth goal on shares of UiPath from $35.00 to $30.00 in a analysis report on Wednesday, Could 18th. Credit score Suisse Group diminished their worth goal on shares of UiPath from $57.50 to $45.00 in a analysis report on Thursday, June 2nd. Lastly, Oppenheimer diminished their worth goal on shares of UiPath from $35.00 to $23.00 and set a “purchase” ranking on the inventory in a analysis report on Thursday, June 2nd. 4 analysts have rated the inventory with a maintain ranking and 13 have assigned a purchase ranking to the corporate’s inventory. In response to MarketBeat.com, UiPath presently has a consensus ranking of “Average Purchase” and a consensus goal worth of $36.06.

UiPath Profile

(Get Score)

UiPath Inc supplies an end-to-end automation platform that provides a spread of robotic course of automation (RPA) options primarily in the USA, Romania, and Japan. The corporate affords a set of interrelated software program to construct, handle, run, interact, measure, and govern automation inside the group.

Featured Articles

Wish to see what different hedge funds are holding PATH? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for UiPath Inc. (NASDAQ:PATHGet Score).

Institutional Ownership by Quarter for UiPath (NASDAQ:PATH)



Obtain Information & Scores for UiPath Each day – Enter your electronic mail deal with beneath to obtain a concise every day abstract of the most recent information and analysts’ rankings for UiPath and associated corporations with MarketBeat.com’s FREE every day electronic mail publication.

Previous post Inexpensive Care Act: Methods to Signal Up and When You Can in 2022
Next post How Lengthy Does CBD Final?